Janus Henderson Group’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$155M Buy
3,175,015
+258,286
+9% +$12.6M 0.08% 210
2025
Q1
$158M Buy
2,916,729
+590,814
+25% +$32M 0.09% 205
2024
Q4
$105M Buy
2,325,915
+455,698
+24% +$20.6M 0.05% 272
2024
Q3
$69.4M Sell
1,870,217
-1,111,342
-37% -$41.2M 0.04% 324
2024
Q2
$91.1M Sell
2,981,559
-688,257
-19% -$21M 0.05% 281
2024
Q1
$107M Buy
3,669,816
+1,057,223
+40% +$30.8M 0.06% 255
2023
Q4
$72M Sell
2,612,593
-459,727
-15% -$12.7M 0.04% 306
2023
Q3
$68.8M Sell
3,072,320
-524,430
-15% -$11.8M 0.05% 298
2023
Q2
$146M Buy
3,596,750
+400,446
+13% +$16.3M 0.09% 204
2023
Q1
$155M Buy
3,196,304
+1,169,162
+58% +$56.6M 0.1% 191
2022
Q4
$77.4M Sell
2,027,142
-2,128,586
-51% -$81.2M 0.06% 290
2022
Q3
$209M Buy
4,155,728
+2,020,052
+95% +$101M 0.08% 231
2022
Q2
$85.6M Sell
2,135,676
-546,298
-20% -$21.9M 0.06% 282
2022
Q1
$100M Sell
2,681,974
-1,219,423
-31% -$45.5M 0.05% 319
2021
Q4
$155M Buy
3,901,397
+326,210
+9% +$13M 0.06% 271
2021
Q3
$133M Buy
3,575,187
+71,273
+2% +$2.65M 0.06% 302
2021
Q2
$148M Buy
3,503,914
+434,774
+14% +$18.4M 0.06% 293
2021
Q1
$145M Buy
3,069,140
+72,719
+2% +$3.44M 0.07% 285
2020
Q4
$183M Buy
2,996,421
+977,858
+48% +$59.7M 0.09% 242
2020
Q3
$94.4M Buy
2,018,563
+201,752
+11% +$9.43M 0.05% 345
2020
Q2
$92.2M Buy
1,816,811
+47,054
+3% +$2.39M 0.05% 338
2020
Q1
$78.9M Buy
1,769,757
+283,095
+19% +$12.6M 0.05% 335
2019
Q4
$71.4M Buy
1,486,662
+133,357
+10% +$6.41M 0.04% 479
2019
Q3
$45.8M Sell
1,353,305
-37,613
-3% -$1.27M 0.02% 601
2019
Q2
$62.6M Sell
1,390,918
-27,561
-2% -$1.24M 0.03% 519
2019
Q1
$53.4M Buy
+1,418,479
New +$53.4M 0.03% 559